Medical Enzyme Technology Market is anticipated to grow up to USD 7.7 Billion by 2032

New York,  global Medical Enzyme Technology market was valued at USD 3.9 Billion in 2022 and it is anticipated to grow up to USD 7.7 Billion by 2032, at a CAGR of 7.0% during the forecast period.

Request for a sample data and methodology of Report –

Enzymes play a crucial role in the metabolic activities of all organisms, whether animal, human, plant, or microbial. They have an extensive range of applications in microbial biotechnology and diagnosis processes. The abnormality of the enzyme metabolism system leads to many metabolic diseases. Further, enzymes can be used as medicines to treat a range of diseases; they are called medicinal enzymes. For example, trypsin can be used not only to accelerate wound healing and dissolve blood clots but also to remove necrotic tissue and inhibit the proliferation of contaminating microorganisms. L-asparaginase can be used to treat cancer by depriving nutrients needed by the growth of cancer cells. Protease (like multi-enzyme tablets) can be used to treat dyspepsia, and it has an anti-inflammatory effect. Moreover, lipase, superoxide dismutase, nattokinase, soybean meal plasmin, and thrombin, among others, can be used to treat diseases.

Market Trends and Drivers

Rising demand for low cost and affordable, yet effective medical treatments, as well as rising prevalence of cancer, is estimated to fuel growth within the global medical enzyme technology market in coming years. Furthermore, rising focus of market players on research and development, as well as growing public awareness regarding benefits of these advanced treatment solutions is positively impacting growth within the global medical enzyme technology market.​

 Major Players in the Global Medical Enzyme Technology Market

The key players in the market are Merck KGaA, Thermo Fisher Scientific Inc., Novozymes, Takeda Pharmaceutical Company Limited, Agilent Technologies, Inc., Genzyme Corporation, Asahi Kasei Corporation, Promega Corporation, Cytiva, and Amano Enzyme Inc ., among others.

COVID-19 Impact:

The current pandemic outbreak of COVID-19 across the globe is further set to result in an exponential growth rate of this segment from 2020 to 2027. For instance, an Indian biotechnology company namely, Richcore Lifesciences is set to introduce 2pivotalenzyme components, applied largely across theCOVID-19 diagnostic kits based on Reverse Transcription Polymerase Chain Reaction (RT-PCR).

Get Customized Report as Per Your Requirement –

Also, a U.S. based manufacturer – Creative Enzymes has expanded the portfolio of healthcare specialty enzymes, acknowledging the present use of Nucleic Acid Test (NAT) and serological tests for COVID-19 diagnosis.

Global Medical Enzyme Technology Market Segmentation

By Enzyme

  • Digestive Enzyme
  • Thrombolytic Enzyme
  • Hydrolases
  • Others

By Application

  • Disease Treatment
  • Diagnostic Tools
  • Biomedical Research

Purchase this report and Get a flat 50% Discount –

 With Global Insight Services, you receive:

  • 10-year forecast to help you make strategic decisions
  • In-depth segmentation which can be customized as per your requirements
  • Free consultation with lead analyst of the report
  • Excel data pack included with all report purchases
  • Robust and transparent research methodology

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

New Report Published by Global Insight Services:

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1–833–761–1700